In DepthEvolution

March of Dimes curtails support for researchers

See allHide authors and affiliations

Science  10 Aug 2018:
Vol. 361, Issue 6402, pp. 538
DOI: 10.1126/science.361.6402.538

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

March of Dimes, the 80-year-old nonprofit organization headquartered in White Plains, New York, that helped develop the polio vaccine and has funded pioneering studies of birth defects, is abruptly scaling back some research grants amid financial struggles. In recent weeks, the group has told 37 of the 42 recipients of its individual investigator awards that it is ending their grants, which average $300,000 over 3 years. Scientists have been caught by surprise and are scrambling to find ways to support graduate students and activities funded by the grants. Kelle Moley, the group's chief scientific officer, attributes the group's struggles to declining donations, particularly from the organization's signature March for Babies.